Ken He Young

Professor

  • 5737 Citations
  • 39 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice

Wang, L., Kumar, M., Deng, Q., Wang, X., Liu, M., Gong, Z., Zhang, S., Ma, X., Xu-Monette, Z., Xiao, M., Yi, Q., Young, K. H., Ramos, K. S. & Li, Y., Jan 1 2019, In : Cancer Letters. 440-441, p. 135-144 10 p.

Research output: Contribution to journalArticle

Plasma Cell Neoplasms
Multiple Myeloma
Blood Cells
Monoclonal Gammopathy of Undetermined Significance
Anemia
9 Citations

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Li, X., Cheng, Y., Zhang, M., Yan, J., Li, L., Fu, X., Zhang, X., Chang, Y., Sun, Z., Yu, H., Zhang, L., Wang, X., Wu, J., Li, Z., Nan, F., Tian, L., Li, W. & Young, K. H., Jan 31 2018, In : Journal of Hematology and Oncology. 11, 1, 15.

Research output: Contribution to journalArticle

T-Cell Lymphoma
Natural Killer T-Cells
Natural Killer Cells
Therapeutics
Non-Hodgkin's Lymphoma

An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma

Li, L., Xiao, S., Zhang, L., Li, X., Fu, X., Wang, X., Wu, J., Sun, Z., Zhang, X., Chang, Y., Nan, F., Yan, J., Li, Z., Shi, M., Young, K. H. & Zhang, M., Jan 1 2018, In : Oncotarget. 9, 22, p. 16213-16219 7 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor-2
Protein-Tyrosine Kinases
Non-Hodgkin's Lymphoma
Disease-Free Survival
Lymphoma
7 Citations
Apoptosis
Biological Phenomena
Hematologic Neoplasms
Therapeutics
Drug Resistance

B-cell receptor–mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma

Li, L., Zhang, J., Chen, J., Xu-Monette, Z., Miao, Y., Xiao, M., Young, K. H., Wang, S., Medeiros, L. J., Wang, L., Ford, R. J. & Pham, L., Oct 25 2018, In : Blood. 132, 17, p. 1805-1817 13 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Interleukin-10
B-Lymphocytes
Chemical activation
Cells